$AVAH

WILLIAMS ROBERT M JR sold $24.0M of AVAH (indirect holdings)

WILLIAMS ROBERT M JR sold 3,000,000 indirectly-held shares of Aveanna Healthcare Holdings, Inc. (AVAH) at $8.01 ($24.03M total) across 3 trades on 2026-06-30.

Original reporting
SEC EDGAR · WILLIAMS ROBERT M JR
Published Jul 2, 2026, 4:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 2, 2026, 4:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AVAH
Neutral
medium confidence
Mentioned
$AVAH
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AVAHNeutralLow
01

Why it matters

The newest actionable element is the disclosed transaction size and price ($8.01) on 2026-06-30; however, the filing does not include new business performance, guidance, or legal/regulatory developments.

02

Market read

Traders may monitor for sentiment/positioning effects from a large insider sale, but there is no fundamental catalyst in the text.

03

What to watch

The sale is indirect and the filing does not state intent; traders should avoid over-weighting insider-sale optics without corroborating signals (earnings, guidance, financing, or regulatory updates).

Relevance 7/10Novelty 5/10Timing: filed 2026-07-02 after-hours/late day; reflects trades dated 2026-06-30

Background

SEC Form 4 insider transaction: Robert M. Williams Jr. (10% owner) reported an indirect open-market sale of Aveanna Healthcare Holdings shares.

Company-level read

Ticker impact

$AVAHNeutralMedium confidence
Context

Aveanna Healthcare Holdings disclosed a 10% owner indirect open-market sale of 3,000,000 shares at $8.01 on 2026-06-30 via Form 4.

Expected impact

Near-term impact is likely limited; any effect would be sentiment-driven around insider-selling optics rather than a fundamental repricing.

Evidence & confidence

Form 4 provides a fresh, concrete transaction (size, price, date), yet the article contains no new company-specific operating or financial catalyst.

Market effects

No direct sector read-through; this is a single-company insider transaction with no stated operational change.

None indicated.

None indicated.

Counterpoint

A 10b5-1 plan is not used here, but the sale could still be for diversification/tax/estate planning rather than a bearish view; without follow-on disclosures, fundamentals may be unchanged.

Key entities

  • Aveanna Healthcare Holdings, Inc.

    Subject of the Form 4 insider transaction; 10% owner sold shares indirectly at $8.01.

  • WILLIAMS ROBERT M JR

    10% owner reporting an open-market sale of 3,000,000 shares across three trades.

Related articles

$AVAHMed

Bain, KKR, KV Asia shortlisted for Malaysia’s Avisena Healthcare stake sale as valuation hits US$368 million: sources

Bain Capital, KKR and KV Asia have been shortlisted to buy a 20–25% minority stake in Malaysia’s Avisena Healthcare, valuing the company at about RM1.5 billion (US$368m), according to two sources. Binding bids are due by end-July. The stake is estimated at RM300–400m. KKR and Bain declined comment; Avisena and KV Asia did not respond.